U.S. Infrastructure Stock News

Natera (NTRA) just closed out FY 2025 with fourth quarter revenue of US$665.5 million and basic EPS of US$0.34, alongside trailing twelve month revenue of about US$2.3 billion and a TTM basic EPS loss of US$1.52. The company has seen quarterly revenue move from US$476.1 million in Q4 2024 to US$665.5 million in Q4 2025, while quarterly basic EPS shifted from a loss of US$0.41 in Q4 2024 to EPS of US$0.34 in Q4 2025. This sets up a results season where investors are focused squarely on how...

Recent analyst updates on nCino (NCNO) have put a fresh spotlight on the stock, as JPMorgan and Barclays revisited their views in light of sector headwinds and rapid AI adoption risks across software. See our latest analysis for nCino. Those analyst comments arrive after a sharp reset in sentiment, with nCino’s share price showing a 30 day return of 30.52% and a year to date share price return of 34.52%. The 1 year total shareholder return of 48.45% and 5 year total shareholder return of...

In February 2026, Rocket Lab USA announced a new multi-launch agreement with BlackSky Technology, adding four dedicated Electron missions to deploy BlackSky’s AI-enabled Gen-3 Earth observation satellites and bringing their total launches together to 17 since 2019. BlackSky also reported fourth-quarter 2025 results showing year-over-year revenue growth to US$35.21 million and a sharply reduced quarterly net loss to US$0.87 million, alongside fresh 2026 revenue guidance and sizeable new Gen-3...

If you are wondering whether Amazon.com is still a reasonable entry at around US$209.97, the key question is whether the current price reflects its underlying business value. After a 121.3% return over 3 years but a 13.6% decline over the past 30 days and a 7.3% decline year to date, some investors are reassessing both the growth potential and the level of risk they are taking on with Amazon.com. Recent news flow around Amazon.com has continued to focus on its role as a large e commerce and...

eInfochips, a subsidiary of Arrow Electronics (NYSE:ARW), has launched NomAIzo, a suite of AI-focused platforms, frameworks, and services. NomAIzo is designed to help customers accelerate edge to enterprise AI adoption across use cases from devices to the cloud. The launch expands Arrow Electronics' presence in AI and high tech engineering services by broadening its edge to cloud offering. For you as an investor, NomAIzo ties directly into what Arrow Electronics already does across...

Lamar Advertising recently declared a past quarterly cash dividend of US$1.60 per share, payable on March 31, 2026, and extended its stock and debt repurchase programs, each authorizing up to US$250.00 million through September 30, 2027. These moves highlight management’s focus on returning capital to shareholders while signaling confidence in the company’s balance sheet and cash-generation capacity. Now we’ll examine how the extended stock repurchase authorization influences Lamar’s...

Relay Therapeutics FY 2025 earnings: revenue modest, losses continue as investors focus on growth potential Relay Therapeutics (RLAY) has wrapped up FY 2025 with Q4 revenue of US$7 million, a basic EPS loss of US$0.32, and net income loss of US$54.89 million, keeping the story firmly in loss-making territory as the market weighs its growth profile. The company has seen quarterly revenue move between US$0 million and US$7.68 million over the past year, while basic EPS losses have ranged from...

In late February 2026, Ferguson Enterprises Inc. reported past fourth-quarter sales of US$7,495 million and net income of US$389 million, alongside five‑month sales of US$12,833 million and net income of US$786 million, while also outlining low‑ to mid‑single‑digit net sales growth expectations for the 2026 calendar year. Along with these results, Ferguson continued to return cash to shareholders through US$248.45 million of share repurchases completing a multi‑year US$4.49 billion program...

China Yuchai International Limited has reported its 2025 full-year results, with sales rising to CNY 24,661.77 million and net income increasing to CNY 537.39 million, alongside higher basic and diluted earnings per share from continuing operations at CNY 14.32. Beyond the headline growth, the company’s performance was underpinned by heavier exposure to high-horsepower and heavy-duty engines, overseas expansion, and higher R&D spending on new energy technologies and advanced...

In February 2026, Expeditors International of Washington reported fourth-quarter 2025 results showing revenue of US$2,855.95 million and net income of US$200.71 million, alongside authorizing a new US$3.00 billion share repurchase program and completing a long-running US$8.72 billion buyback. While full-year 2025 revenue and earnings per share grew modestly, weaker ocean freight performance and higher headcount weighed on quarterly profitability. We will now examine how softer ocean freight...

Conference update and pipeline focus Corvus Pharmaceuticals (CRVS) has come into focus after its appearance at the Oppenheimer 36th Annual Healthcare Life Sciences Conference, where management outlined fresh details on lead candidate soquelitinib across several immune related indications. The company highlighted plans for a phase III interim analysis in peripheral T cell lymphoma by year end 2026, new phase II studies in asthma and hidradenitis suppurativa, and early atopic dermatitis data...

Central Garden & Pet reported a 6% year over year revenue decline in its latest quarter. The company expanded its share repurchase program, signaling an increased focus on buybacks. Central Garden & Pet also refreshed its board of directors with new appointments. Central Garden & Pet, traded as NasdaqGS:CENT, released results that showed weaker revenue and earnings alongside the slowest revenue growth among its household product peers. The stock last closed at $39.18 and is up 22.1% over...

If you are wondering whether Universal Health Services is attractively priced or starting to look expensive, you are in the right place for a clear look at what the market might be implying about its value. The shares last closed at US$206.10, with returns of a 10.6% decline over 7 days, 1.5% over 30 days, a 6.3% decline year to date, 18.1% over 1 year, 64.2% over 3 years, and 61.1% over 5 years. This gives you a broad sense of how sentiment around the stock has shifted over time. Recent...

ON Semiconductor is sharpening its focus on higher margin areas, including silicon carbide products and AI data center power solutions. The company is reallocating capital toward projects it views as higher return and scaling back exposure to weaker end markets such as electric vehicles and smartphones. Management is emphasizing capital discipline and targeted investment as it reshapes the business mix of NasdaqGS:ON. For investors tracking NasdaqGS:ON, this reset comes with the stock...

Coastal Financial recently reported a past-quarter update showing a 1.3% year-on-year revenue decline, missing analysts’ expectations by 16.6%, even as loans receivable grew 1.2% and deposits rose 4.3%. Management emphasized the potential of its Banking-as-a-Service platform, highlighting plans to expand product offerings and scale new and existing partnerships despite the disappointing revenue and net interest income performance. We’ll now examine how Coastal Financial’s revenue shortfall...

Vera Therapeutics reported full-year 2025 results showing a net loss of US$299.62 million, while advancing atacicept with positive Phase 3 IgA nephropathy data and securing FDA priority review with a July 7, 2026 PDUFA date. Alongside filing a US$191.89 million Class A common stock shelf registration for an ESOP-related offering, the company highlighted that its cash, equivalents, marketable securities and debt facility availability are expected to fund operations through potential atacicept...

Pulse Biosciences, Inc. reported a full-year 2025 net loss of US$72.78 million, widening from US$53.59 million in 2024, and filed new universal and ESOP-related shelf registrations alongside a reconfigured at-the-market common stock offering. At the same time, FDA approval to begin a paroxysmal atrial fibrillation study with the nPulse Cardiac Catheter System and a planned thyroid cancer collaboration with The University of Texas MD Anderson Cancer Center underscore how the company is...

The Honest Company, Inc. recently reported that full-year 2025 sales slipped to US$371.32 million while net loss more than doubled to US$15.69 million, and simultaneously announced a new US$25 million share repurchase program funded by cash on hand and operating cash flows. Alongside this, management issued 2026 guidance calling for an anticipated high-teens percentage decline in reported revenue due to exited categories, while emphasizing 4% to 6% organic growth as the core metric of its...

In February 2026, Verizon Communications Inc. completed the sale of €2.25 billion and £600 million of junior subordinated unsecured notes due 2056, including step-up and fixed-to-floating rate Eurobonds that are callable and carry a 0.65% discount to par. This move adds long-dated, junior capital to Verizon’s balance sheet, potentially supporting funding for network investment and ongoing transformation without immediately relying on common equity. We’ll now examine how this large junior...

What Southwest Airlines (LUV) investors may be watching now Recent trading in Southwest Airlines (LUV) has drawn attention after a sharp move in the share price over the past month and past 3 months, prompting investors to reassess the airline’s current valuation and fundamentals. See our latest analysis for Southwest Airlines. At a share price of US$49.26, Southwest Airlines has seen a 30 day share price return of 20.56% and a 90 day share price return of 41.51%, while the 1 year total...

If you are wondering whether Evercore's current share price fairly reflects its underlying worth, you are not alone. This article is designed to help you size that up clearly. The stock last closed at US$308.84, with returns of 29.2% over 1 year and a 144.5% gain over 3 years, even though the past 7 days and 30 days show declines of 5.9% and 15.0% and the year to date return sits at a 12.1% decline. Recent coverage has focused on Evercore's role as a major independent investment bank in...

In February 2026, Sezzle Inc. reported full-year 2025 results showing sales of US$450.28 million and net income of US$133.13 million, alongside guidance for 2026 calling for total revenue growth of 25% to 30% and the launch of Sezzle Mobile, an integrated unlimited phone plan starting at US$29.99 per month within its app. These updates highlight Sezzle’s shift from a pure buy-now-pay-later platform toward a broader financial and everyday-spending hub, with subscription, payments, and now...

In recent months, Quantum Computing Inc. (QCi) raised US$1.25 billion in cash, closed a US$110.0 million acquisition of Luminar Semiconductor, secured contracts with NASA and NIST, completed a quantum photonic chip foundry in Tempe, Arizona, and announced it would report Q4 and full-year 2025 results on March 2, 2026. These moves, alongside the company’s first U.S. commercial sale of quantum cybersecurity solutions to a top-five bank and growing Department of Defense work, highlight QCi’s...

Symbotic (SYM) is back in focus after reporting first quarter results that exceeded expectations on both profitability and revenue, supported by improved margins and what management describes as strong operational execution. See our latest analysis for Symbotic. At a share price of $54.78, Symbotic has seen a 90 day share price return decline of 34.61%. Its 1 year total shareholder return of 141.32% and 3 year total shareholder return of about 3.3x point to strong longer term momentum despite...